Schaefer, Tabea C.
Greive, Svenja
Mencl, Stine
Heiland, Sabine
Kramer, Martin
Möhlenbruch, Markus A.
Kleinschnitz, Christoph
Bendszus, Martin
Vollherbst, Dominik F. http://orcid.org/0000-0002-8992-4757
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 26 May 2023
Accepted: 22 August 2023
First Online: 4 September 2023
Declarations
:
: M.A. Möhlenbruch has received consulting honoraria, speaker honoraria, and travel support outside this work from Codman, Covidien/Medtronic, MicroVention, Phenox, and Stryker. M. Bendszus reports board membership: DSMB Vascular Dynamics; consultancy: Roche, Guerbet, Codman; grants/grants pending: DFG, Hopp Foundation, Novartis, Siemens, Guerbet, Stryker, Covidien; payment for lectures (including service on speaker bureaus): Novartis, Roche, Guerbet, Teva, Bayer, Codman. D.F. Vollherbst reports consultancy for Medtronic and paid lectures for Cerenovus, and a research grant by MicroVention (unrelated to this work). T.C. Schaefer, S. Greive, S. Mencl, S. Heiland, M. Kramer, and C. Kleinschnitz declare that they have no competing interests.
: All experiments were performed in accordance with the Guide for the Care and Use of Laboratory Animals (Directive 2010/63/EU of the European Parliament). State Animal Care and Ethics Committee approval was obtained (registry number: 35-9185.81/G-183/20).